Labcorp ROA 2010-2023 | LH
Current and historical return on assets (ROA) values for Labcorp (LH) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Labcorp ROA - Return on Assets Historical Data |
| Date |
TTM Net Income |
Total Assets |
Return on Assets |
| 2023-12-31 |
$0.42B |
$16.73B |
2.34% |
| 2023-09-30 |
$0.66B |
$16.89B |
3.53% |
| 2023-06-30 |
$0.83B |
$17.72B |
4.27% |
| 2023-03-31 |
$1.00B |
$20.20B |
4.97% |
| 2022-12-31 |
$1.28B |
$20.16B |
6.31% |
| 2022-09-30 |
$1.76B |
$19.83B |
8.64% |
| 2022-06-30 |
$1.99B |
$20.40B |
9.67% |
| 2022-03-31 |
$2.10B |
$20.73B |
10.19% |
| 2021-12-31 |
$2.38B |
$20.39B |
11.58% |
| 2021-09-30 |
$2.76B |
$20.87B |
13.51% |
| 2021-06-30 |
$2.88B |
$20.42B |
14.45% |
| 2021-03-31 |
$2.64B |
$20.42B |
13.72% |
| 2020-12-31 |
$1.56B |
$20.07B |
8.42% |
| 2020-09-30 |
$0.85B |
$18.74B |
4.70% |
| 2020-06-30 |
$0.36B |
$17.85B |
2.04% |
| 2020-03-31 |
$0.32B |
$17.30B |
1.81% |
| 2019-12-31 |
$0.82B |
$18.05B |
4.67% |
| 2019-09-30 |
$0.76B |
$17.85B |
4.39% |
| 2019-06-30 |
$0.85B |
$17.74B |
5.05% |
| 2019-03-31 |
$0.90B |
$16.97B |
5.41% |
| 2018-12-31 |
$0.88B |
$16.19B |
5.34% |
| 2018-09-30 |
$1.41B |
$16.66B |
8.48% |
| 2018-06-30 |
$1.27B |
$16.51B |
7.60% |
| 2018-03-31 |
$1.22B |
$16.83B |
7.48% |
| 2017-12-31 |
$1.23B |
$16.67B |
7.83% |
| 2017-09-30 |
$0.70B |
$16.69B |
4.67% |
| 2017-06-30 |
$0.71B |
$14.90B |
4.91% |
| 2017-03-31 |
$0.73B |
$14.43B |
5.10% |
| 2016-12-31 |
$0.71B |
$14.25B |
4.97% |
| 2016-09-30 |
$0.66B |
$14.48B |
4.60% |
| 2016-06-30 |
$0.63B |
$14.20B |
4.43% |
| 2016-03-31 |
$0.60B |
$14.41B |
4.17% |
| 2015-12-31 |
$0.44B |
$14.11B |
3.07% |
| 2015-09-30 |
$0.45B |
$14.42B |
3.56% |
| 2015-06-30 |
$0.43B |
$14.47B |
3.99% |
| 2015-03-31 |
$0.40B |
$14.15B |
4.48% |
| 2014-12-31 |
$0.51B |
$7.30B |
7.13% |
| 2014-09-30 |
$0.52B |
$7.23B |
7.30% |
| 2014-06-30 |
$0.53B |
$7.15B |
7.60% |
| 2014-03-31 |
$0.54B |
$6.99B |
7.92% |
| 2013-12-31 |
$0.57B |
$6.97B |
8.55% |
| 2013-09-30 |
$0.57B |
$6.69B |
8.51% |
| 2013-06-30 |
$0.57B |
$6.59B |
8.47% |
| 2013-03-31 |
$0.57B |
$6.57B |
8.65% |
| 2012-12-31 |
$0.58B |
$6.80B |
9.03% |
| 2012-09-30 |
$0.60B |
$6.81B |
9.51% |
| 2012-06-30 |
$0.58B |
$6.10B |
9.58% |
| 2012-03-31 |
$0.55B |
$6.13B |
9.06% |
| 2011-12-31 |
$0.52B |
$6.11B |
8.46% |
| 2011-09-30 |
$0.52B |
$6.05B |
8.39% |
| 2011-06-30 |
$0.52B |
$6.17B |
8.85% |
| 2011-03-31 |
$0.55B |
$6.20B |
9.88% |
| 2010-12-31 |
$0.56B |
$6.19B |
10.58% |
| 2010-09-30 |
$0.57B |
$5.05B |
11.53% |
| 2010-06-30 |
$0.56B |
$4.96B |
11.47% |
| 2010-03-31 |
$0.54B |
$4.93B |
11.25% |
| 2009-12-31 |
$0.54B |
$4.84B |
11.31% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$16.779B |
$12.162B |
|
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
|
